GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
FRA:BV3
Delisted

Bavarian Nordic A/S Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
20.64€
+0 (+0%)
At Close: Dec 22, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 20.64€ 20.64€ Friday, 22nd Dec 2023 BV3.F stock ended at 20.64€. During the day the stock fluctuated 0% from a day low at 20.64€ to a day high of 20.64€.
90 days 20.18€ 21.17€
52 weeks 18.20€ 35.60€

Historical Bavarian Nordic A/S prices

Date Open High Low Close Volume
2023-12-22 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-21 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-20 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-19 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-18 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-15 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-14 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-13 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-12 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-11 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-08 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-07 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-06 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-05 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-04 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-12-01 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-30 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-29 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-28 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-27 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-24 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-23 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-22 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-21 20.64€ 20.64€ 20.64€ 20.64€ 0
2023-11-20 20.64€ 20.64€ 20.64€ 20.64€ 0
Click to get the best stock tips daily for free!

About Bavarian Nordic A/S

Bavarian Nordic A/S Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... BV3.F Profile

Golden Star

Ticker Date Change Price
DOOR Apr 17 0.0305% $131.35
LNG Apr 17 3.29% $156.81
FCN Apr 16 1.75% $207.62
ELV Apr 16 4.82% $506.97
FTSL Apr 16 0.217% $46.08
AKR Apr 05 3.15% $16.53
ITCI Apr 05 5.74% $68.44
SARK Mar 28 18.79% $26.88
SON Mar 26 0.83% $56.64
ARCC Mar 25 2.34% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT